<DOC>
	<DOCNO>NCT00253708</DOCNO>
	<brief_summary>RATIONALE : Massage therapy may help relieve symptom associated cancer . It yet know type massage therapy effective treating symptom patient cancer . PURPOSE : This randomized clinical trial study different type massage therapy compare well work treat symptom patient locally advanced metastatic cancer .</brief_summary>
	<brief_title>Massage Therapy Treating Symptoms Patients With Locally Advanced Metastatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare safety tolerate dose ( i.e. , duration , technique , degree pressure ) professional massage therapy v professional simple presence ( touch ) massage therapy v usual care follow caregiver massage therapy v usual care patient locally advanced metastatic cancer . - Correlate therapy pain , anxiety , depression , nausea , shortness breath patient . - Correlate therapy patient quality life caregiver anxiety depression . - Determine feasibility teach family caregiver provide massage therapy subsequent use massage caregiver . - Determine effect caregiver massage therapy patient caregiver . - Determine feasibility acceptability among patient massage therapist simple presence ( touch ) massage therapy control group . OUTLINE : This randomize , control , pilot study . Patients randomize 1 3 treatment arm . - Arm I ( professional massage therapy ) : Hospitalized patient offer massage therapy license massage therapist 15-45 minute daily duration hospital stay . Outpatient oncology clinic patient offer home-based massage therapy license massage therapist 15-45 minute daily 3 day . - Arm II ( usual care ) : Patients receive usual care symptom management . - Arm III ( professional simple presence [ touch ] massage therapy ) : Hospitalized patient offer simple presence ( touch ) massage therapy comprise room visit license massage therapist place his/her hand 12 inch patient without direct touch 15-45 minute . Treatment offer daily duration hospital stay . Outpatient oncology clinic patient offer home-based simple presence ( touch ) massage therapy license massage therapist 15-45 minute daily 3 day . All patient randomize ( second time ) 1 2 treatment arm . - Arm I ( caregiver massage therapy ) : Previously hospitalize patient offer home-based caregiver massage therapy 1 month . Outpatient oncology clinic patient offer home-based caregiver massage therapy 3 week . - Arm II ( usual care ) : Patients receive usual care symptom management . Hospitalized patient complete questionnaire addressing symptom , quality life , satisfaction symptom control , time spend bed daily day 1-5 , every 3 day hospital , 1 week , 2 week , 1 month discharge hospital . Outpatient oncology clinic patient complete similar telephone questionnaire baseline , 1 week , 1 month . PROJECTED ACCRUAL : Approximately 100 patient accrue study .</detailed_description>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Locally advance , unresectable disease 1 follow type : Nonsmall cell lung cancer Stage III IV disease Gastric cancer Esophageal cancer Hepatobiliary cancer Colon cancer Metastatic disease 1 follow type : Small cell lung cancer Renal cancer Bladder cancer Melanoma Prostate cancer Breast cancer Ovarian cancer Not amenable curative treatment Receiving treatment Beth Israel Deaconess Medical Center ( BIDMC ) Anticipated hospital stay &gt; 3 day OR register patient outpatient oncology clinic Must reside ≤ 50 mile BIDMC Current symptom ( i.e. , pain , nausea , shortness breath , anxiety , depression ) rating ≥ 3/10 patient report ( 2/10 patient receive opioid analgesic within past 24 hour ) PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No cognitive impairment reason would preclude give informed consent PRIOR CONCURRENT THERAPY : Other No prior randomization study No concurrent massage energy therapy ( e.g. , Reiki )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>depression</keyword>
	<keyword>nausea vomit</keyword>
	<keyword>pain</keyword>
	<keyword>psychosocial effect cancer treatment</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>localize unresectable adult primary liver cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>ovarian stromal cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>recurrent renal cell cancer</keyword>
	<keyword>recurrent melanoma</keyword>
</DOC>